Autopsy report · NCT02702167

High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa

“COVID-19 pandemic restrictions.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months before it started.
• Ran for about 3 years 6 months before it stopped.
• 90 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University Health Network, Toronto

Sponsor type

University, hospital or other

Conditions

Bulimia Nervosa; Anorexia Nervosa

Interventions

High-frequency rTMS; Low-frequency rTMS; Sham rTMS

Participants

90

Sites

1

Countries

Canada

Trials that died the same way

• Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
  “Health restrictions due to the COVID-19 pandemic” (92% match in meaning)
• Clinical Trial Evaluating the Safety and Efficacy of the Use of Chitosan Gel in Patients With Chronic Wounds
  “COVID-19 restrictions” (92% match in meaning)
• RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches
  “Covid restrictions” (86% match in meaning)
• Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
  “COVID-19 Research Restrictions” (85% match in meaning)
• Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
  “COVID-19 pandemic” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.